Back to Search
Start Over
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®).
- Source :
- Cancer Chemotherapy & Pharmacology; Aug2007, Vol. 60 Issue 2, p219-228, 10p, 1 Diagram, 2 Charts, 6 Graphs
- Publication Year :
- 2007
-
Abstract
- The aim of the present study is to determine in HeLa cells and in human lymphocytes, by an easy and fast method, the induction of oxidative damage to plasma membrane lipids and nuclear DNA by Casiopeínas<superscript>®</superscript>, which are recently synthesized coordination complexes that have been considered as a promising chemotherapeutic alternative for the treatment of cancer, since they have shown cytotoxicity and genotoxicity in several cancer cell lines and xenotransplanted tumours. The presence of an oxidized copper atom in their structure strongly suggests that their mode of action seems to be related to reactive oxygen species (ROS) generation after copper atom reduction through the Fenton and Haber–Weiss system. Lipid peroxidation was evaluated as thiobarbituric acid reactive malondialdehyde, cytotoxicity by the fluorescein diacetate/ethidium bromide stain and genotoxicity as DNA fragmentation by the comet assay. Cells were treated with ten different Casiopeínas in a concentration range higher than their IC<subscript>50</subscript> (10–100 μM), both oxidized and reduced in the presence of ascorbic acid. In almost all the cases, copper reduction enhanced cytotoxicity but, unlike copper nitrate used as positive control, none of them induced appreciable lipid peroxidation. Three Casiopeínas: Cas Igly, Cas-III-H-a and Cas-III-E-a, showed low, moderate and high rates of genotoxicity, respectively, and this effect was enhanced upon addition of ascorbic acid. These results suggest that ROS generation might be the cause of cytotoxicity, which seems to be related to initial genetic damage rather than to lipid peroxidation. HeLa cells showed to be more sensitive than normal cells. [ABSTRACT FROM AUTHOR]
- Subjects :
- CANCER treatment
HELA cells
CANCER cells
LYMPHOCYTES
ANTINEOPLASTIC agents
Subjects
Details
- Language :
- English
- ISSN :
- 03445704
- Volume :
- 60
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Cancer Chemotherapy & Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 25006775
- Full Text :
- https://doi.org/10.1007/s00280-006-0364-9